Recombinant adeno-associated virus serotype 2 effectively transduces primary rat brain astrocytes and microglia

被引:8
作者
Gong, Y
Chen, SZ
Sonntag, CF
Sumners, C
Klein, RL
King, MA
Hughes, JA
Meyer, EM
机构
[1] Univ Florida, Dept Pharmacol & Therapeut, Coll Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Pharm, Dept Neurosci, Gainesville, FL 32610 USA
[4] LSUHSC S, Dept Pharmacol & Therapeut, Shreveport, LA 71130 USA
[5] Malcom Randall Vet Adm Med Ctr, Gainesville, FL 32602 USA
来源
BRAIN RESEARCH PROTOCOLS | 2004年 / 14卷 / 01期
关键词
recombinant adeno-associated virus 2; green fluorescent protein; primary neurons; astrocytes; microglia;
D O I
10.1016/j.brainresprot.2004.08.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant adeno-associated virus-2 (rAAV2) under control of the chicken beta actin promoter/truncated CMV enhancer (CBA) was investigated for its ability to transduce primary cultures of rat brain neurons, microglia and astrocytes. This vector was highly effective in all three cell types in heparin-sensitive manners (astrocytes, microglia and neurons transduced by >98%, 75%, and 95%, respectively). However, astrocytes co-cultured with neurons were not transduced. rAAV2/CBA is an important new method for genetic manipulation of brain cells, though this may be modulated by interactions among cell types. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 17 条
  • [1] Selective and rapid uptake of adeno-associated virus type 2 in brain
    Bartlett, JS
    Samulski, RJ
    McCown, TJ
    [J]. HUMAN GENE THERAPY, 1998, 9 (08) : 1181 - 1186
  • [2] TGF-β1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia
    Chen, SZ
    Luo, DF
    Streit, WJ
    Harrison, JK
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) : 46 - 55
  • [3] CHARACTERIZATION OF GLUCOCORTICOID TYPE-II RECEPTORS IN NEURONAL AND GLIAL CULTURES FROM RAT-BRAIN
    CHOU, YC
    LUTTGE, WG
    SUMNERS, C
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 1990, 2 (01) : 29 - 38
  • [4] Tetracycline-inducible transgene expression mediated by a single AAV vector
    Chtarto, A
    Bender, HU
    Hanemann, CO
    Kemp, T
    Lehtonen, E
    Levivier, M
    Brotchi, J
    Velu, T
    Tenenbaum, L
    [J]. GENE THERAPY, 2003, 10 (01) : 84 - 94
  • [5] Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors
    Cucchiarini, M
    Ren, XL
    Perides, G
    Terwilliger, EF
    [J]. GENE THERAPY, 2003, 10 (08) : 657 - 667
  • [6] Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
    Davidson, BL
    Stein, CS
    Heth, JA
    Martins, I
    Kotin, RM
    Derksen, TA
    Zabner, J
    Ghodsi, A
    Chiorini, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3428 - 3432
  • [7] Novel tools for production and purification of recombinant adenoassociated virus vectors
    Grimm, D
    Kern, A
    Rittner, K
    Kleinschmidt, JA
    [J]. HUMAN GENE THERAPY, 1998, 9 (18) : 2745 - 2760
  • [8] Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain
    Klein, RL
    Hamby, ME
    Gong, Y
    Hirko, AC
    Wang, S
    Hughes, JA
    King, MA
    Meyer, EM
    [J]. EXPERIMENTAL NEUROLOGY, 2002, 176 (01) : 66 - 74
  • [9] Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions
    Kube, DM
    Srivastava, A
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (16) : 3375 - 3376
  • [10] Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units
    Kügler, S
    Lingor, P
    Schöll, U
    Zolotukhin, S
    Bähr, M
    [J]. VIROLOGY, 2003, 311 (01) : 89 - 95